Introduction: Explanation of the philosophy, structure and ways to use of the book
Section 1: Principles of evidenced-based medicine.
1] Searching for evidence.
2] Appraising the literature.
3] Economic evaluation of cancer treatments.
4] Evidence-based approach to diagnostic techniques.
5] Strengths and weaknesses of prognostic and predictive factors in cancer.
Section 2: Cancer prevention.
6] Stopping smoking.
7] Breast cancer.
8] Colorectal cancer.
9] Skin cancer.
10] Cervix cancer.
11] Hepatocellular cancer.
12] Diet and alcohol in cancer prevention.
Section 3: Screening for cancer.
13] breast cancer.
14] cervical cancer.
15 Colorectal cancer.
16] Prostate cancer.
17] Ovarian cancer.
18] Lung cancer.
19] Stomach cancer.
Section 4: Management of tumours of the respiratory system.
21] Non-small cell lung cancer.
22] Small cell lung cancer.
Section 5: Management of head and neck cancers.
24] Oral and salivary gland cancers.
25] Nasoparyngeal cancers.
26] Laryngeal cancers.
Section 6: Management of tumours of the gastrointestinal system.
27] Oesophageal cancer.
28] Stomach cancer.
29] Pancreatic cancer.
30] Hepatobiliary cancers.
31] Small bowel cancers.
32] Cancer of the colon and rectum.
33] Anal cancer.
Section 7: Management of tumours of the urogenital system.
34] Kidney cancer.
35] Bladder cancer.
36] Prostate cancer.
37] Penile cancer.
38] Testicular Germ cell cancer.
Section 8: Management of tumours of the female reproductive system.
39] Ovarian, primary peritoneal and fallopian tube cancers.
40] Cancer of the endometrium.
41] Cancer of the cervix.
42] Cancer of the vagina.
43] Cancer of the vulva.
44] Ovarian germ cell tumours.
45] Gestational trophoblastic tumours.
46] Uterine sarcomas.
Section 9: Management of breast cancer.
47] Early breast cancer.
48] Advanced or recurrent breast cancer.
Section 10: Management of skin cancer.
49] Cutaneous melanoma.
50] Basal cell cancer.
51] Squamous cancer of the skin.
52] Kaposi’s sarcoma.
Section 11: Management of sarcomas.
53] Soft tissue sarcomas.
54] Bone sarcomas.
Section 12: Management of central nervous system cancers.
55] Central nervous system tumours.
Section 13: Management of tumours of the eye and associated structures.
56] Uveal melanoma.
57] Orbital and adnexal tumours.
Section 14: Management of the elderly and those with co-morbid conditions.
58] Evidence on adjusting treatment of cancer to take into account co-morbidity.
Section 15: Palliative management of cancer.
59] Assessing the needs of cancer patients.
60] Managing pain from cancer.
61] Managing other common symptoms of cancer.
Section 16: Managing complications of cancer and its treatment.
62] Managing neutropenia, sepsis and thrombocytopenia.
63] Managing venous thrombosis and pulmonary embolism.
64] Serous effusions.
65] Metabolic complications.
66] Disseminated intravascular coagulation.
67] Spinal metastatic disease and pathological fractures.
Section 17: Assessing the evidence for new treatments under development.
68] Vaccines for cancer.
69] Small molecules and targeted therapies.
70] New cytotoxic agents.
71] Hadron radiotherapy.
72] Scheduling and techniques used to deliver higher radiation doses
Section 18: Complementary and alternative treatments for cancer.
73] Evidence-based assessment of CAM treatments.
Section 19: Assessing how is cancer care best delivered.
74] Optimising delivery of cancer care.
Section 20: Aids in delivering evidence-based care.
75] Essential materials for helping deliver care and sources of addition support